Zur Kurzanzeige

dc.contributor.author
Quero, Lilian
dc.contributor.author
Tiaden, André N.
dc.contributor.author
Hanser, Edveena
dc.contributor.author
Roux, Julien
dc.contributor.author
Laski, Artur
dc.contributor.author
Hall, Jonathan
dc.contributor.author
Kyburz, Diego
dc.date.accessioned
2020-02-24T10:49:33Z
dc.date.available
2020-02-22T04:25:26Z
dc.date.available
2020-02-24T10:49:33Z
dc.date.issued
2020-01
dc.identifier.issn
1664-3224
dc.identifier.other
10.3389/fimmu.2019.03087
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/401192
dc.identifier.doi
10.3929/ethz-b-000401192
dc.description.abstract
Objectives: Macrophages are conventionally classified as pro-inflammatory (M1) and anti-inflammatory (M2) functional types. There is evidence for a predominance of macrophages with an inflammatory phenotype (M1) in the rheumatoid arthritis (RA) synovium. MicroRNAs (miRs) play a pivotal role in regulating the inflammatory response in innate immune cells and are found at dysregulated levels in RA patients. Here we explored miRs that tune the inflammatory function of M2-macrophages. Methods: Expression profiles of miR-221-3p and miR-155-5p were analyzed in clinical samples from RA, other inflammatory arthritis (OIA), osteoarthritis (OA), and healthy donors (HD) by qPCR. In vitro generated macrophages were transfected with miR-mimics and inhibitors. Transcriptome profiling through RNA-sequencing was performed on M2-macrophages overexpressing miR-221-3p mimic with or without LPS treatment. Secretion of IL-6, IL-10, IL-12, IL-8, and CXCL13 was measured in M1- and M2-macrophages upon TLR2/TLR3/TLR4-stimulation using ELISA. Inflammatory pathways including NF-κB, IRF3, MAPKs, and JAK3/STAT3 were evaluated by immunoblotting. Direct target interaction of miR-221-3p and predicted target sites in 3'UTR of JAK3 were examined by luciferase reporter gene assay. Results: miR-221-3p in synovial tissue and fluid was increased in RA vs. OA or OIA. Endogenous expression levels of miR-221-3p and miR-155-5p were higher in M1- than M2-macrophages derived from RA patients or HD. TLR4-stimulation of M1- and M2-macrophages resulted in downregulation of miR-221-3p, but upregulation of miR-155-5p. M2-macrophages transfected with miR-221-3p mimics secreted less IL-10 and CXCL13 but more IL-6 and IL-8, exhibited downregulation of JAK3 protein and decreased pSTAT3 activation. JAK3 was identified as new direct target of miR-221-3p in macrophages. Co-transfection of miR-221-3p/miR-155-5p mimics in M2-macrophages increased M1-specific IL-12 secretion. Conclusions: miR-221-3p acts as a regulator of TLR4-induced inflammatory M2-macrophage function by directly targeting JAK3. Dysregulated miR-221-3p expression, as seen in synovium of RA patients, leads to a diminished anti-inflammatory response and drives M2-macrophages to exhibit a M1-cytokine profile.
en_US
dc.format
application/pdf
en_US
dc.language.iso
en
en_US
dc.publisher
Frontiers Media
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
innate immunity
en_US
dc.subject
macrophages (M1/M2)
en_US
dc.subject
microRNAs
en_US
dc.subject
TLRs
en_US
dc.subject
RNA-seq
en_US
dc.subject
JAK3/STAT3
en_US
dc.subject
rheumatoid arthritis
en_US
dc.title
miR-221-3p Drives the Shift of M2-Macrophages to a Pro-Inflammatory Function by Suppressing JAK3/STAT3 Activation
en_US
dc.type
Journal Article
dc.rights.license
Creative Commons Attribution 4.0 International
dc.date.published
2020-01-27
ethz.journal.title
Frontiers in Immunology
ethz.journal.volume
10
en_US
ethz.journal.abbreviated
Front Immunol
ethz.pages.start
3087
en_US
ethz.size
17 p.
en_US
ethz.version.deposit
publishedVersion
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
Lausanne
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03760 - Hall, Jonathan / Hall, Jonathan
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.::02534 - Institut für Pharmazeutische Wiss. / Institute of Pharmaceutical Sciences::03760 - Hall, Jonathan / Hall, Jonathan
ethz.date.deposited
2020-02-22T04:25:33Z
ethz.source
SCOPUS
ethz.eth
yes
en_US
ethz.availability
Open access
en_US
ethz.rosetta.installDate
2020-02-24T10:49:44Z
ethz.rosetta.lastUpdated
2024-02-02T10:28:34Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=miR-221-3p%20Drives%20the%20Shift%20of%20M2-Macrophages%20to%20a%20Pro-Inflammatory%20Function%20by%20Suppressing%20JAK3/STAT3%20Activation&rft.jtitle=Frontiers%20in%20Immunology&rft.date=2020-01&rft.volume=10&rft.spage=3087&rft.issn=1664-3224&rft.au=Quero,%20Lilian&Tiaden,%20Andr%C3%A9%20N.&Hanser,%20Edveena&Roux,%20Julien&Laski,%20Artur&rft.genre=article&rft_id=info:doi/10.3389/fimmu.2019.03087&
 Printexemplar via ETH-Bibliothek suchen

Dateien zu diesem Eintrag

Thumbnail

Publikationstyp

Zur Kurzanzeige